This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: National Center for Geriatrics and Gerontology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Akiyoshi Kawai: Innovator in Pharmaceutical Research
Introduction
Akiyoshi Kawai is a notable inventor based in Obu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit amyloid fibril formation. His work is crucial in addressing various health issues related to amyloid diseases.
Latest Patents
Akiyoshi Kawai holds a patent for an oxadiazole derivative and a pharmaceutical containing the same. This invention is characterized as an amyloid fibril formation inhibitor, comprising a compound represented by specific general formulae (I) to (III). This innovative approach has the potential to impact the treatment of diseases associated with amyloid fibrils.
Career Highlights
Kawai is affiliated with the National Center for Geriatrics and Gerontology, where he conducts research aimed at improving health outcomes for the elderly. His dedication to advancing pharmaceutical science is evident in his focused research efforts and innovative solutions.
Collaborations
Kawai collaborates with Katsuhiko Yanagisawa, a fellow researcher, to further explore the implications of their findings in the field of geriatrics and pharmaceuticals.
Conclusion
Akiyoshi Kawai's contributions to pharmaceutical research, particularly through his patent on amyloid fibril inhibitors, highlight his role as an innovator in the field. His work continues to pave the way for advancements in treating age-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile